Brief: Kiromic Biopharma Inc Shares Open 1.7% Below IPO Price In Debut on Nasdaq
16/10/2020 17:03
Oct 16 (Reuters) -
* KIROMIC BIOPHARMA INC SHARES OPEN AT $11.80 IN DEBUT ON
NASDAQ
VERSUS IPO PRICE OF $12.00/SHARE
Further company coverage: KRBP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiromic Biopharma
See all newsBrief: Kiromic Biopharma Files For Offering Up To 1 Million Units
Brief: Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'
Brief: Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation
Brief: Kiromic Biopharma Reports Favorable Results At Six Weeks From Fourth Patient In Deltacel-01 Clinical Trial
Brief: Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site